Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 708,658 | 817,966 | 799,159 | 693,420 | 631,477 |
| Marketable Securities | 140,823 | 139,148 | 124,210 | 126,393 | 132,875 |
| Receivables | 293,228 | 262,245 | 266,865 | 283,315 | 289,597 |
| Inventories | 37,568 | 35,623 | 32,398 | 30,353 | 26,111 |
| Other current assets | 217,559 | 182,130 | 192,585 | 275,262 | 215,923 |
| TOTAL | $1,451,355 | $1,487,804 | $1,469,365 | $1,462,596 | $1,349,415 |
| Non-Current Assets | |||||
| PPE Net | 479,321 | 481,581 | 501,666 | 508,021 | 512,168 |
| Investments And Advances | 92,876 | 97,812 | 98,103 | 100,797 | 124,024 |
| Intangibles | 570,329 | 575,836 | 603,641 | 469,010 | 475,297 |
| Other Non-Current Assets | 341,648 | 336,733 | 335,163 | 295,709 | 287,619 |
| TOTAL | $1,484,174 | $1,491,962 | $1,538,573 | $1,373,537 | $1,399,108 |
| Total Assets | $2,935,529 | $2,979,766 | $3,007,938 | $2,836,133 | $2,748,523 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,395 | 20,925 | 15,395 | 17,170 | 17,361 |
| Accrued Expenses | 327,186 | 351,399 | 346,525 | 246,757 | 230,346 |
| Other current liabilities | 33,404 | 31,505 | 36,586 | 22,963 | 22,356 |
| TOTAL | $394,096 | $422,226 | $423,036 | $314,011 | $290,447 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 178,523 | 184,634 | 202,173 | 165,943 | 165,478 |
| TOTAL | $179,123 | $185,356 | $202,179 | $166,130 | $165,551 |
| Total Liabilities | $573,219 | $607,582 | $625,215 | $480,141 | $455,998 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,579 | 95,276 | 95,641 | 95,506 | 95,822 |
| Common Shares | 94 | 94 | 94 | 95 | 95 |
| Retained earnings | 2,367,182 | 2,391,990 | 2,397,307 | 2,378,115 | 2,319,358 |
| Other shareholders' equity | -4,966 | -19,900 | -14,678 | -22,218 | -26,928 |
| TOTAL | $2,362,310 | $2,372,184 | $2,382,723 | $2,355,992 | $2,292,525 |
| Total Liabilities And Equity | $2,935,529 | $2,979,766 | $3,007,938 | $2,836,133 | $2,748,523 |